|
Denis Coleman is a founder, investor, and mentor of numerous technology and software start-ups in Silicon Valley. Coleman is currently the Chairman and President of Solus Biosystems, a startup with a hardware/software platform to accelerate drug discovery by measuring the interactions of proteins and drugs. Coleman Co-Founded Symantec Corporation (NASDAQ: SYMC) in 1983, and served there through 1988 as VP of R&D. Coleman's other companies include DCL, C Level Design Corporation (an EDA company), Financial Engines, Neoforma (NASDAQ: NEOF), Visioneer Communications (merged to form SSFT), and Cognitive Technology Corporation. Coleman has served these companies in many roles including Director, Founder, and Investor. Coleman holds a BS and an MS in Mechanical Engineering and a MS in Management, all from M.I.T., and a Ph.D. in Management from Stanford University. Coleman has taught on the faculty of Stanford University, and is credited with 14 academic publications and one book. | 